Ascend Wellness Holdings (AAWH) Change in Inventory (2020 - 2026)
Ascend Wellness Holdings' (AAWH) quarterly Change in Inventory came in at $1.8 million in Q1 2026, up 406.62% year-on-year from $356479.2 in Q1 2025, and down 38.38% quarter-over-quarter from $2.9 million in Q4 2025.
Ascend Wellness Holdings (AAWH) Change in Inventory (2020 - 2026) Analysis & Trends
Ascend Wellness Holdings' Change in Inventory history runs 7 years deep, the most recent figure standing at $1.8 million for Q1 2026.
- On a quarterly basis, Change in Inventory rose 406.62% year-over-year to $1.8 million in Q1 2026; TTM through Mar 2026 was $13.1 million, a 188.81% increase from a year earlier, with the FY2025 full-year figure at $10.7 million, up 692.32% from the prior year.
- Change in Inventory slipped to $1.8 million in Q1 2026 per AAWH's latest filing, from $2.9 million in the prior quarter.
- Across five years, Change in Inventory topped out at $17.4 million in Q1 2022 and bottomed at -$9.7 million in Q2 2023.
- The 5-year median for Change in Inventory is $3.0 million (2023), against an average of $4.1 million.
- Across the five-year window, Change in Inventory sank 232.32% in 2024 and surged 406.62% in 2026, its largest moves.
- Year by year, Change in Inventory stood at $9.1 million in 2022, then rose by 1.47% to $9.2 million in 2023, then plunged by 171.46% to -$6.6 million in 2024, then soared by 144.62% to $2.9 million in 2025, then slumped by 38.38% to $1.8 million in 2026.
- Per Business Quant, the three latest AAWH Change in Inventory figures stand at $1.8 million (Q1 2026), $2.9 million (Q4 2025), and $5.5 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -93.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 114.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 119.24 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 40.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 123.00 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | -4.30 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Ascend Wellness Holdings | 83.00 Mn | 22.91 Mn | 44.88 Mn | 1.81 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.81 Mn |
| Mar 31, 2026 | 1.81 Mn |
| Dec 31, 2025 | 2.93 Mn |
| Dec 31, 2025 | 2.93 Mn |
| Sep 30, 2025 | 5.48 Mn |
| Sep 30, 2025 | 5.48 Mn |
| Jun 30, 2025 | 2.89 Mn |
| Jun 30, 2025 | 2.89 Mn |
| Mar 31, 2025 | -589,000.00 |
| Mar 31, 2025 | -589,000.00 |
| Dec 31, 2024 | -6.57 Mn |
| Dec 31, 2024 | -6.57 Mn |
| Sep 30, 2024 | -3.96 Mn |
| Sep 30, 2024 | -3.96 Mn |
| Jun 30, 2024 | -3.64 Mn |
| Jun 30, 2024 | -3.64 Mn |
| Mar 31, 2024 | 12.36 Mn |
| Mar 31, 2024 | 12.36 Mn |
| Dec 31, 2023 | 9.19 Mn |
| Dec 31, 2023 | 9.19 Mn |